RecruitingNCT06714916

Optimising Renal Tumour Management Through Artificial Intelligence Modules

Mutimodal Artificial Intelligence for Optimising Renal Tumour Management: Diagnosis, Surgery and Prognosis


Sponsor

Shao Pengfei

Enrollment

2,100 participants

Start Date

Jan 1, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this observational study is to improve the management of people with renal tumour by multimodal artificial intelligence(AI). It will also measure the accuracy of the predictions from AI models. The main questions it aims to answer are: 1. whether the AI module can accurately provide tumor-related information such as Benign or malignant, subtypes, grading, stage, etc. by learning from preoperative CT images. 2. whether the AI module can help clinicians find out the most suitable surgical programme for people with renal tumor. 3. whether the AI module can integrate CT images and pathology slides, offering supplementary prognostic information to improve postoperative survival. Participants who complete a CT(usually Contrast-enhanced CT, CECT) examination and undergo radical or partial nephrectomy will carry out active surveillance and record postoperative survival data for 5 years.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is developing and validating artificial intelligence (AI) tools to help doctors make better decisions when treating kidney tumors. The AI will analyze CT scans and patient data to assist with surgical planning and predicting outcomes. **You may be eligible if...** - You have a kidney tumor that can be treated with surgery - You had a contrast-enhanced CT scan within 30 days before your planned surgery - You have given informed consent to participate **You may NOT be eligible if...** - Any key information from your medical records is missing - Your cancer had already spread to other organs at the time of discovery - You have already received treatment (surgery, targeted therapy, or immunotherapy) for this tumor Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

The First Affiliated Hospital of Nanjing Medical University (Jiangsu Provincial People's Hospital)

Nanjing, Jiangsu, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06714916


Related Trials